TRIZAL study: switching from successful HAART to TrizivirTM (abacavir‐lamivudine‐zidovudine combination tablet): 48 weeks efficacy, safety and adherence results
暂无分享,去创建一个
B. Gazzard | C. Katlama | A. Lazzarin | J. Mallolas | N. Clumeck | A. Lafeuillade | S. Fenske | J. Mamet | L. Beauvais | Lauriane Beauvais